The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGF-i) following stereotactic body radiotherapy (SBRT).
Brandon M. Barney
No relevant relationships to disclose
Svetomir Markovic
No relevant relationships to disclose
Nadia N. Laack
No relevant relationships to disclose
Robert C. Miller
No relevant relationships to disclose
Jann Nagina Sarkaria
No relevant relationships to disclose
Orlan Kenneth Macdonald
No relevant relationships to disclose
Kenneth R Olivier
No relevant relationships to disclose